DMRA
Damora Therapeutics, Inc.stockNASDAQ
Market OpenNov 19, 2026 9:51:09 AM EST
23.34USD+1.633%(+0.38)6,230
DMRA Financials
In Q3 FY 2026 (ended ), Damora Therapeutics, Inc. (DMRA) reported net income of −$31.99M, operating cash flow of −$17.23M, and assets of $532.63M (filed ).
Loading financial statements…